Phase II
Direct
Evaluation
An NIH SBIR Phase II grant is an alluring opportunity for a medical innovation company that has already been conducting some initial research and development. Our expert team of grant writers will help evaluate your current project for eligibility and competitiveness for a Direct to Phase II grant application.
Significance-Innovation Analysis™
Part of the BHGC advantage is our proprietary Significance-Innovation Analysis™. As a Direct to Phase II project, we will conduct this analysis to create a compelling significance and innovation story to create the most compelling and competitive Phase II grant application possible for your project. This process also helps determine the specific aims and key milestones differentiating your project from other Phase II applications.
Preliminary Data Presentation
Strong and comprehensive preliminary data presentation will differentiate your Direct to Phase II grant application. Preliminary data for a Direct to Phase II project must demonstrate technical feasibility of your innovative technology to create your proposed product or service. Our BHGC team of grant writers will help you prioritize the preliminary data you have already collected to demonstrate both the feasibility standards of a Phase I application as well as connecting those data to your Phase II appropriate specific aims and milestones.
Specific Aims and Milestones
Compelling Phase II specific aims and milestones will build upon your team’s prior successes and data. As a BHGC partner, we will help identify your proposed workplan and translate it into the NIH language of specific aims and milestones. Additionally, our team of grant writers will help craft these specific aims to highlight your focus on product development and commercialization. As professional grant writers, we focus on crafting specific and quantitative milestones related to each specific aim in a comprehensive and compelling plan for success to maximize clear communication of your project to NIH grant reviewers.
Commercialization Analysis
As a project applying for an NIH SBIR Direct to Phase II grant, your team will need to present a strong commercialization plan. Our team of grant writers will assist in the development and writing of a compelling commercialization plan to demonstrate the commercial potential of your innovative solution.
Application Material Assembly
A Direct to Phase II application might be overwhelming. Not only does your team need to present preliminary data demonstrating the technical feasibility of your innovative technology, but also the proposed research and develop workplan must convey a compelling story with a meaningful product development endpoint at the completion of the Phase II project. BHGC’s team of grant writers will not only write an assemble these materials into a coherent grant application, but we will work with your team to facilitate meetings with NIH Program Officers during critical steps in the grant process, such as receiving your impact score and reviewing summary statements.
Reporting and Next Steps
Direct to Phase II funding provides applicants with the resources necessary to accomplish significant research and development goals in order to advance technological innovations towards the marketplace. As a comprehensive grant writing service provider, Blue Haven Grant Consultants will also help produce required grant reports for all of our clients.
When final reports are completed, you may find additional grant opportunities to further accelerate your path towards commercialization. As we collaborate on your Direct to Phase II application, we also look ahead at potential funding opportunities following completion of your Phase II project.
Contact us today to learn more about how our project evaluation services can benefit your grant application. Together, let's turn your innovative ideas into impactful projects that make a difference.